Pre-Clinical Activity of Combined LSD1 and mTORC1 Inhibition in MLL-translocated Acute Myeloid Leukaemia

Leukemia - United Kingdom
doi 10.1038/s41375-019-0659-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MLL Gene Alterations in Acute Myeloid Leukaemia (11q23/Mll+ AML)

2013English

Acute Aleukaemic Myeloid Leukaemia

BMJ
1943English

Prognosis in Acute Myeloid Leukaemia.

BMJ
1981English

The Clinical and Prognostic Significance of FOXN3 Downregulation in Acute Myeloid Leukaemia

International Journal of Laboratory Hematology
BiochemistryMedicineClinical BiochemistryHematology
2020English

Razoxane in Treatment of Acute Myeloid Leukaemia.

BMJ
1978English

G1 Cell-Cycle Arrest and Apoptosis by Histone Deacetylase Inhibition in MLL-AF9 Acute Myeloid Leukemia Cells Is P21 Dependent and MLL-AF9 Independent

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Pcn107 - Burden and Costs of Acute Myeloid Leukaemia in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

MN1 Is Indispensable for MLL-rearranged Acute Myeloid Leukemia

Haematologica
Hematology
2019English

Cord Blood Transplant for Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy